Introduction
Rheumatoid arthritis (RA) is one of the most common human systemic autoimmune diseases. It is characterized by inflammation of synovial tissues and the formation of rheumatoid pannus, which is capable of eroding adjacent cartilage and bone and causing subsequent joint destruction. Previous studies have indicated that the risk of developing the disease in siblings of affected individuals (l sib ) is 2-17 times higher than in the general population, suggesting the importance of genetic factors in RA. 1 The only locus that has been conclusively associated is the HLA-DRB1 locus, which accounts for about one-third of the genetic component. [2] [3] [4] Many other potential candidate genes of smaller effect have to be discovered.
Vitamin D plays an important role in the regulation of calcium and phosphorus metabolism. 5 Recently, an immunoregulatory role of vitamin D has been postulated, based on the fact that the activation of human leukocytes causes the expression of the vitamin D receptor (VDR). Vitamin D is also involved in interleukin-2 (IL-2) inhibition and antibody production and in lymphocyte proliferation suppression and the generation of cytotoxic lymphocytes. 6, 7 In addition, monocytes constitutively express VDR, as well as activated but not resting lymphocytes. 8, 9 Within the rheumatoid joint, the active form of vitamin D has been shown to be synthesized in RA synovium and is thought to be stimulated by interleukin-1 (IL-1) and/or IL-2. 10 The actions of 1,25 (OH) 2 D 3 are mediated via the nuclear VDR. Its gene, located on chromosome 12q12-14, harbors several polymorphisms and was found to be associated with several autoimmune diseases such as Addison's disease, type I diabetes and systemic lupus erythematosus. [11] [12] [13] [14] Given the shared genetic susceptibility among autoimmune diseases and the association of VDR variants with other autoimmune diseases, we investigated the distribution of three VDR polymorphisms, FokI T4C (rs 10735810) located in exon 2, BsmI A4G (rs 1544410) located in intron 8 and TaqI C4T (rs 731236) located in exon 9, in 100 trios affected with one RA patient and both parents. A second set of 100 trios was used for replication.
Results

Linkage disequilibrium and Hardy-Weinberg equilibrium tests in set 1
The observed FokI, BsmI and TaqI genotype frequencies were in accordance with the Hardy-Weinberg equili-brium in controls (data not shown). Analysis of linkage disequilibrium between the FokI and both BsmI and TaqI markers did not show any significant result (P ¼ 0.87 and 0.62, respectively). However, a complete linkage disequilibrium between BsmI and TaqI polymorphisms was found.
Test for association of VDR markers in set 1 RA trios AFBAC analysis revealed a significant difference of F and f alleles between transmitted and nontransmitted frequencies (P ¼ 0.01) ( Table 1a ). The transmission of the F allele from heterozygous parents (61 of 97 transmissions) (62.88%) showed an excess over that would be expected by Mendel's law (50%) (w 2 ¼ 6.44, P ¼ 0.01) ( Table 1a) . Global GRR analysis showed a significant difference between RA patients and controls (w 2 ¼ 6.21, P ¼ 0.04). The F/F genotype was more frequent in RA patients compared to controls (45 RA cases vs 30 controls, P ¼ 0.01) (Table 1b) .
To establish whether FokI association with RA was dependent on the presence of HLA-DRB1 SE allele, the transmission of F allele was analyzed in the subgroup of families where patient carried at least one HLA-DRB1 SE allele. Our results showed that F allele was preferentially transmitted (50 transmitted vs 29 nontransmitted, P ¼ 0.02). Similar results were found when patients were stratified according to the presence of erosion (53 transmitted vs 31 nontransmitted, P ¼ 0.02) as well as the presence of an autoimmune disease including RA in first-degree relative and/or in index (24 transmitted vs 12 nontransmitted, P ¼ 0.05).
In order to test haplotype transmission of VDR FokI, BsmI and TaqI alleles, haplotypes were determined. Five different haplotypes at the VDR gene locus were inferred with a frequency higher than 5%. None of these haplotypes showed a significant disequilibrium of transmission to patients (P40.05) ( Table 2) .
Results of test for association of FokI marker in set 2
The association found in the first set of RA trios was tested in a second set of 100 families. AFBAC analysis did not reveal any significant difference between transmitted and nontransmitted frequencies (P ¼ 0.21) ( Table 3a ). The transmission of the F allele from heterozygous parents (49 of 86 times (57%) also trends toward overtransmission, but does not reach statistical significance (w 2 ¼ 1.86, P ¼ 0.2). At the genotypic level, the F/F genotype showed more evidence for association with RA (P ¼ 0.14) than at the allelic level (Table 3b ).
Stratifying patients according to the presence of at least one HLA-DRB1 SE allele and erosion did not reveal any evidence of association of allele F with RA by TDT with 36 transmitted vs 30 nontransmitted (P ¼ 0.55) and 35 transmitted vs 32 nontransmitted (P ¼ 0.72) for HLA-DRB1 and erosion, respectively. Similar results were found when patients were stratified according to the presence of an autoimmune disease including RA in first-degree relative and/or in index (15 transmitted vs 12 nontransmitted, P ¼ 0.56). 
Power computation
In these calculations, we used the frequency of the F allele in the general population (60%) as being that of the risk allele. Four GRR values were considered (g ¼ 1.1, 1.4, 1.7 and 2.0) and power computations were made under multiplicative gene effect model as suggested by previous studies. 15, 16 Note that the estimate of GRR based on transmissions in sets 1 and 2 combined is about
A power of 50% is reached for a g value close to 1.7. For g ¼ 1.5, we found a power of about 38% in set 1 and 31% in set 2. This means that if the actual g value is 1.5, the probability of finding a positive association when it actually exists is 0.38 and 0.31 in sets 1 and 2, respectively. The probability of finding a positive result in both sets is thus 0.38 Â 0.31 ¼ 0.12 (as both sets are independent). This means that out of 100 samples (of 100 triads each), the replication would be found only in 12.
To detect a gene having this GRR with 80% power (at 5% significance level) a number of informative families between 80 and 100 is needed (depending on the risk allele frequency).
Results of test for association of FokI marker in sets 1 and 2 When we combined set 1 and 2, AFBAC analysis revealed a significant difference of F and f alleles between transmitted and nontransmitted frequencies (P ¼ 0.007). The transmission of the F allele from heterozygous parents (110 of 183 times (60.1%)) showed an excess over that expected by Mendel 0 s law (50%, P ¼ 0.006). Global GRR analysis showed a significant difference between RA patients and controls (P ¼ 0.02) and the F/F genotype was more frequent in RA patients compared to controls (93 RA cases vs 67 controls (P ¼ 0.005).
Discussion
We studied the association of three VDR polymorphisms (FokI, BsmI and TaqI) in RA and found that allele F and genotype FF appeared to be associated with susceptibility to RA in set 1. Following this descriptive analysis on set 1, replication study on a second set of 100 trios showed the same tendency. Stratification for HLA-DRB1 SE alleles, erosion or autoimmune disease including RA in first-degree relative and/or in index did not show stronger association. The results obtained in the 'autoimmune' subgroup may outline a specific association of VDR with RA and not with the general process of autoimmune diseases.
The lack of replication evidence in set 2 could be explained by the smaller number of informative families with at least one heterozygous parent (64 vs 74 in set 1). In fact, power calculation showed that the probability of detecting the gene when it exists was weak (below 1/3) for a gene with minor effect (GRRo1.5) under a multiplicative mode. At least 80 triads are needed to get an 80% power for a positive replication. This association was emphasized when both sets are combined.
Previous studies claimed that at least five times as many families are needed to replicate an original linkage finding if criteria for significance are the same at the two stages. 17 However, with multiple susceptibility genes contributing to a trait, some genes will by chance be most prevalent and are detected in a given data set, whereas they would be very difficult to find in a new data set because they are unlikely to be again the most frequent in this data set. 18 Neither BsmI nor TaqI alleles showed an association with RA in set 1. No association was found with any haplotype of three markers; this result could be explained by the lack of association of both BsmI and TaqI polymorphisms and the lack of linkage disequilibrium between the associated FokI polymorphism and the two others. In fact, Nejentsev et al 19 found that FokI SNP is not in linkage disequilibrium with any other SNP of the VDR gene. Moreover, these authors showed that BsmI and TaqI SNP localized to a single block of linkage disequilibrium and did not capture any information on a large part of the VDR gene, especially on the 5 0 region. Linkage studies in our whole-genome scan of Caucasian RA families have revealed no evidence for linkage with the 12q14 region, where VDR gene is located. 20 It should, however, be noted that failure to detect linkage of a region does not exclude the possibility of a disease risk gene in that region. 21 Our results are in contrast with a case/control study in German population, which showed no evidence of RA association with VDR. 22 This could be due to heterogeneity between populations or lack of power in the German study caused by the small samples used (62 cases and 40 controls). Moreover, we used a case familybased control design to avoid the heterogeneity caused by mismatch between populations in case/controls studies. The additional advantages of such studies are described in Huizinga et al. 23 The F associated allele in a VDR protein has three amino acids less than the f variant. 24 FokI alleles differ functionally 25, 26 due to altered VDR affinity and transactivation of VDR elements containing promoter construct in HeLa and COS-7 cells. 27 An in vitro study demonstrated an increased transcription rate (1.7-fold) of the VDR gene in cells with the F/F genotype. 28 An overexpression of VDR gene may affect the expression of genes containing such VDR response element. This could dysregulate the Th1/Th2 balance and therefore could cause the development of autoimmune process of RA. Our present findings suggest that polymorphisms in the VDR gene could have some effects on RA etiopathogenesis. These effects are of interest given recent studies 29 demonstrating the existence of different VDR-mediated immunoregulatory properties of vitamin D. The clinical course of RA is characterized by bone and joint destruction and it is therefore conceivable that polymorphic genes whose products have a direct effect on suggested a role in immunoregulation and possibly that joint inflammation could be influenced by VDR polymorphisms. Alternatively, the VDR gene may not be responsible for the primary disease association but may be in linkage disequilibrium with a nearby novel disease-related locus.
In summary, our findings suggest that VDR or a closely linked gene is associated with RA in the French population. However, the mechanism by which such polymorphisms are associated with RA is unknown and our findings need to be confirmed by a functional study.
Patients and methods
Patients Set 1 RA sample. All subjects provided informed consent, and the ethics committee of Hô pital Bicêtre (Kremlin-Bicêtre, Assistance Publique-Hô pitaux de Paris, France), approved the study. RA families were recruited through a national media campaign followed by selection of individuals who fulfilled the 1987 American College of Rheumatology criteria for RA 30 according to the physicians in charge of the patients. All clinical data were reviewed by a rheumatologist university fellow. A total of 100 French Caucasian trio families (with four French Caucasian grand parents) were investigated. Among the 100 RA patients, 87 were women and 13 were men; their mean age at disease onset was 32 years. In all, 72 were rheumatoid factor (RF) positive, 78 carried at least one HLA-DRB1 susceptibility alleles 'shared epitope' (SE) (DRB1*0101, 0102, 0401, 0404, 0405, 0408, 1001), 2 90 presented with erosive disease and 31 presented nodules.
Four patients have another autoimmune disease, and in 29 families at least one first-degree relative had an auto-immune disease including RA, thyroid auto-immune diseases, myasthenia gravis, systemic lupus erythematosus, vitiligo and pernicious anemia. Set 2 RA sample. A total of 100 French Caucasian trio families (with four French Caucasian grand parents) were investigated. Among the 100 RA patients, 90 were women and 10 were men; their mean age at disease onset was 31.2 years. In all, 72 were RF positive, 80 carried at least one HLA-DRB1 SE, 78 had erosive disease and 20 presented nodules. In all, 10 patients have another autoimmune disease, and in 23 families at least one first-degree relative had an autoimmune disease including RA, thyroid autoimmune diseases, celiac disease, vitiligo, insulin-dependant diabetes mellitus and primary Sjö gren's syndrome.
Genotype analysis DNA was isolated from whole blood according to standard protocols. Genotypes for three restriction polymorphic sites (FokI, BsmI and TaqI) were identified by the polymerase chain reaction followed by restriction fragment length polymorphism (PCR/RFLP) method. The FokI, BsmI and TaqI polymorphisms were studied using primers described by Pani et al.
12 PCR amplifications were performed on each sample in a 25 ml reaction volume consisting of 10 Â PCR buffer (Perkin Elmer, Boston, MA, USA), 0.5 mM of each primer, 0.1 mM of each dNTP, 1.25 U of Taq Gold DNA polymerase (Perkin Elmer), 3 mM MgCl 2 and 50 ng of genomic DNA, diluted to the final volume with H 2 O. PCR amplification was carried out using Techne thermocycler. Each PCR was performed using a hot start procedure, and amplification was carried out using 35 cycles of denaturation at 941C for 40 s, with annealing temperature for 30 s followed by an elongation step at 721C for 1 min. One final cycle of the extension was performed at 721C for 2 min.
Regarding FokI polymorphism (annealing temperature: 601C), the 265-bp amplified fragment was digested with FokI, generating two fragments of 196 and 69 bp when the FokI restriction site is present. For examining the BsmI polymorphism (annealing temperature: 661C), the resulting 825-bp fragment was digested with BsmI, generating two fragments of 175 and 650 bp when the BsmI restriction site is present. The TaqI polymorphism (annealing temperature: 601C) was examined in a 740-bp fragment of intron 8/exon 9. Digestion with TaqI resulted in three fragments of 290, 245 and 205 bp in the presence of the polymorphic site and two fragments of 245 and 495 bp in its absence, due to an additional monomorphic TaqI site. In samples heterozygous for the respective restriction sites, both digested and undigested DNA fragments were visible. Genotypes were assessed blindly by two independent investigators (AM and EPT) and were designated by a lower case letter for the presence of a restriction site and by a capital letter for its absence. In order to test the quality of genotyping, we performed a control quality test by randomly genotyping 10% of the sample. The results were the same as in the first genotyping.
Statistical analysis
Prior to association tests, we looked at Hardy-Weinberg equilibrium in virtual controls (constituted by parental alleles nontransmitted to RA patients).
Association between each polymorphism and RA was examined by three different methods: affected familybased controls (AFBAC) was used to compare transmitted and nontransmitted allele frequencies across all families. 31 Transmission disequilibrium test (TDT) was used to detect preferential transmission of the RFLP alleles to the affected subjects 32 and genotype relative risk (GRR) (a single genotype vs the others), was used to compare the genotype distribution in controls and patients. 33 VDR haplotypes were inferred using the algorithm implemented in Genehunter ('haplo' option). AFBAC, TDT and GRR were performed on haplotypes as described above and linkage disequilibrium was tested for each pair of markers. The haplotype frequencies were estimated by the Arlequin version 2 program. Significance of P-values was assessed using a Bonferroni correction at 5% (a P-value less than 0.05/3 ¼ 0.017 is considered significant).
Power calculation
In order to evaluate the information of the two sets, we have carried out power calculation using TDT-Power calculator. 34 This program allows computation of power of the TDT given a number of informative families, the frequency of the risk allele in the population and the genotypic relative risks (defined by the parameter g of Risch and Merikangas). 15 Calculation of the number of families needed to obtain an 80% power is also carried out.
